Imaging Efficacy of [18F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath-A Phase 3, Prospective Multicenter Study.
Saved in:
| Title: | Imaging Efficacy of [18F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath-A Phase 3, Prospective Multicenter Study. |
|---|---|
| Authors: | Fanti S; Nuclear Medicine, IRCCS AOU di Bologna, Bologna, Italy; stefano.fanti@aosp.bo.it., Robles Barba JJ; Nuclear Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain., Behr S; University of California San Francisco, San Francisco, California., Maurer T; Department of Urology and Martini-Klinik Prostate Cancer Center, University of Hamburg-Eppendorf, Hamburg, Germany., Paredes P; Clinic Hospital Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Walz J; Department of Urology, Institut Paoli-Calmettes Cancer Centre, Marseille, France., Duch J; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Perdigo MS; Hospital Universitari Vall d'Hebron, Barcelona, Spain., Mainta IC; Division of Nuclear Medicine, Diagnostic Department, Geneva University Hospitals, University of Geneva, Geneva, Switzerland., Bonnefoy PB; Service de Médecine Nucléaire, CHU de Saint-Etienne, Saint-Étienne, France., Coulanges M; Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland., Tang J; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey., Seigne C; Novartis Pharma AG, Basel, Switzerland; and., Wilke C; Novartis Pharma AG, Basel, Switzerland; and., Catafau AM; Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland., Iagaru A; Stanford University, Stanford, California., Aggarwal R; University of California San Francisco, San Francisco, California. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2025 Aug 01; Vol. 66 (8), pp. 1210-1216. Date of Electronic Publication: 2025 Aug 01. |
| Publication Type: | Journal Article; Multicenter Study; Clinical Trial, Phase III; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1535-5667 |
|---|---|
| DOI: | 10.2967/jnumed.124.269266 |
